Therapeutic Interchange
Sacramento County Dose Conversion Summary
Inhaled Corticosteroid Dose Conversion Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Formulary Agents |
Non-Formulary Agents |
|
|
|
|
|
|
|
|
|
QVAR 40 mcg |
QVAR 80 mcg |
Flovent 110mcg |
Flovent 220 mcg |
Aerobid |
Azmacort |
Pulmicort |
(Beclomethasone Diproprionate) |
(Beclomethasone Diproprionate) |
(Fluticasone) |
(Fluticasone) |
(Flunisolide) |
(Triamcinolone) |
(Budesonide) |
|
Dosing Conversion |
|
2 puffs BID |
1 puff BID |
1 puff QD |
|
1 puff BID |
1 puff BID |
1 puff QD |
4 puffs BID |
2 puffs BID |
1 puff BID |
1 puff QD |
2 puffs BID |
2 puffs BID |
2 puffs QD |
8 puffs BID |
4 puffs BID |
2 puffs BID |
1 puff BID |
4 puffs BID |
4 puffs BID |
2 puffs QAM and 1 puff QPM |
16 puffs BID |
8 puffs BID |
|
2 puffs BID |
8 puffs BID |
8 puffs BID |
4 puffs BID |
Nasal Steroid Dose Conversion Table |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Formulary Agents |
Non-Formulary Agents |
|
|
Budesonide |
Beclomethasone (Beconase AQ) |
Ciclesonide (Omnaris) |
Fluticasone Furoate (Veramyst) |
Fluticasone Propionate |
Flunisolide |
Mometasone (Nasonex) |
Triamcinolone (Nasacort AQ)
|
(Rhinocort AQ®) |
(Flonase®) |
(Nasarel®) |
|
Dosing Conversion |
2-3 Sprays in each nostril QD |
1 spray in each nostril BID |
2 sprays in each nostril QD |
2 sprays in each nostril QD |
1 spray in each nostril QD |
2 Sprays in each nostril BID |
2 sprays in each nostril QD |
1 spray in each nostril QD |
> 4 Sprays in each nostril QD |
2 sprays in each nostril BID |
|
|
2 sprays in each nostril QD or 1 spray in each nostril BID |
2 Sprays in each nostril TID |
|
2 sprays in each nostril QD |
ACE-Inhibitors Dose Conversion Table |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Formulary Agents |
Non-Formulary Agents |
|
|
Quinapril (Accupril) |
Lisinopril (Prinivil®, Zestril®) |
Benazepril (Lotensin®) |
Enalapril (Vasotec®) |
Fosinopril (Monopril®) |
Moexipril (Univasc®) |
Perindopril (Aceon®) |
Ramipril (Altace®) |
Trandolapril (Mavik®) |
|
Dosage Conversion |
|
5 mg/day |
5 mg/day |
5 mg/day |
5 mg/day (2 divided doses)
|
5 mg/day |
3.75 mg/day |
2 mg/day |
1.25 mg/day |
1 mg/day |
10 mg/day |
10 mg/day |
10 mg/day |
10 mg/day (2 divided doses)
|
10 mg/day |
7.5 mg/day |
4 mg/day |
2.5 mg/day |
2 mg/day |
20 mg/day |
20 mg/day |
20 mg/day |
20 mg/day (2 divided doses)
|
20 mg/day |
15 mg/day |
8 mg/day |
5 mg/day |
4 mg/day |
40 mg/day |
40 mg/day |
40 mg/day |
40 mg/day (2 divided doses)
|
40 mg/day |
30 mg/day |
16 mg/day |
10-20 mg/day |
8 mg/day |
ARB Dose Conversion Table |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Formulary Agents |
Non-Formulary Agents |
|
|
|
|
|
|
Atacand (Candesartan) |
Cozaar (Losartan) |
Avapro (Irbesartan) |
Teveten (Eprosartan) |
Benicar (Olmesartan) |
Micardis (Telmisartan) |
Diovan (Valsartan) |
1st Line |
2nd Line |
|
|
|
|
|
|
Dosage Conversion |
|
4 mg QD |
25 mg QD |
75 mg QD |
400 mg QD |
5 mg QD |
|
40 mg QD |
8mg QD |
50 mg QD |
150 mg QD |
600 mg QD |
10 mg QD |
20 mg QD |
80 mg QD |
16 mg QD |
100 mg QD |
300 mg QD |
800 mg QD |
20 mg QD |
40 mg QD |
160 mg QD |
32 mg QD |
|
|
|
40 mg QD |
80 mg QD |
320 mg QD |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PPI Dose Conversion Table |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Formulary Agent |
Non-Formulary Agents |
|
|
|
|
|
|
Prilosec® |
Nexium® |
Prevacid® |
Protonix ® |
Aciphex® |
|
|
20mg |
20mg |
15mg |
20mg |
20mg |
|
|
40mg |
40mg |
30mg |
40mg |
20mg |
|
|
|
|
|
|
|
|
|
|
H-2 Blocker Dose Conversion Table |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Formulary Agent |
Non-Formulary Agent |
|
|
|
|
|
|
|
|
|
|
Ranitidine |
Cimetidine |
Famotidine |
|
|
|
|
(Zantac) |
(Tagament) |
(Pepcid) |
|
|
|
|
150 mg |
200 mg |
20 mg |
|
|
|
|
300 mg |
400 mg |
40 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
Statin Dose Conversion Table |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Formulary Agents |
|
Formulary Agents |
|
|
|
Atorvastatin (Lipitor) |
Simvastatin (Zocor) |
Rosuvastatin (Crestor) |
Lovastatin (Mevacor) |
Pravastatin (Pravachol) |
Fluvastatin (Lescol) |
|
1st Line
|
2nd Line
|
2nd Line
|
|
|
|
Dosage Conversion |
|
(based on average % decrease in LDL) |
|
|
|
10 mg |
10 mg |
5 mg |
20 mg |
10 mg (19%) |
20 mg (17%) |
|
10 mg |
10 mg (28%) |
5 mg |
20 mg (29%) |
20 mg (24%) |
40 mg (23%) |
|
10 mg |
20 mg (35%) |
5 mg |
40 mg (31%) |
40 mg (34%) |
80 mg (33%) |
|
20 mg (38%) |
40 mg (40%) |
10 mg (43%) |
80 mg (40-48%) |
80 mg (40%) |
|
|
40 mg (46%) |
80 mg (48%) |
20 mg (50%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lexapro Dose Conversion Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Formulary Agent |
Non-Formulary Agent |
|
|
|
|
|
|
|
|
|
|
|
|
Citalopram (Celexa) |
Escitalopram (Lexapro) |
|
|
|
|
|
20 mg |
10 mg |
|
|
|
|
|
40 mg |
20 mg |
|
|
|
|
|